Japanese Physicians Favor DPP-4 Inhibitors For Treatment-Naive Patients
This article was originally published in PharmAsia News
Executive Summary
A survey shows that 24% of physicians in Japan consider prescribing DPP-4 inhibitors for treatment-naïve patients with type 2 diabetes